Iovance Biotherapeutics Inc. Common Stock vs Keurig Dr Pepper Inc. Common Stock — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.18 (market cap $6.04B), while Keurig Dr Pepper Inc. Common Stock trades at $31.13 (market cap $42.54B). The key difference: Keurig Dr Pepper Inc. Common Stock is far larger — about 7× Iovance Biotherapeutics Inc. Common Stock's market cap, and Keurig Dr Pepper Inc. Common Stock pays a 2.94% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Keurig Dr Pepper Inc. Common Stock for 0 Days on average.
| IOVA | KDP | |
|---|---|---|
Market Cap | $6.04B | $42.54B |
Volume | 14,805,993 | 14,530,234 |
Sector | Health | Consumer Staples |
52-Week High | $14.82 | $33.50 |
52-Week Low | $1.81 | $25.31 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.97B | $71.00B |
Dividend Yield | — | 2.94% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →Keurig Dr Pepper produces and distributes coffee, soft drinks, juices, and other beverages. It also operates the Keurig single-serve coffee system.
Read more on KDP →